Clinical Trial Update: A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating a modified-release formulation RTN-001 in adults with uncontrolled hypertension. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• RTN-001 Modified Release (RTN-001)

Snippet

Sponsor: Retension Pharmaceuticals. Inc. | Conditions: Uncontrolled Hypertension | Phase 2 | Status: RECRUITING